Work

Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?

Year: 2016

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2016.10.038

Authors: Caela R. Miller, Nicole P. Chappell, Caitlin Sledge, Charles A. Leath, Neil T. Phippen, Laura J. Havrilesky, Jason C. Barnett

Institutions: Brooke Army Medical Center, University of Alabama at Birmingham, Walter Reed National Military Medical Center, Duke Medical Center

Language: English

Topic: Gestational Trophoblastic Disease Studies

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: G7484487955

OpenAlex ID: W2046217249

FWCI: 0.905

Cites: 14

Cited by: 10

Related to: 10